Canadian scientists develop vaccine for piglets
By Canadian Packaging staffGeneral Huvepharma Inc. PEDV vaccine pig vaccine Porcine Epidemic Diarrhea Virus vaccine University of Saskatchewan
Prototype vaccine for Porcine Epidemic Diarrhea Virus (PEDV) for piglets to be field tested in Saskatchewan and Manitoba.
Reports from the University of Saskatchewan indicate that researchers there have developed a prototype vaccine for piglets against Porcine Epidemic Diarrhea Virus (PEDV), and are now field testing it in Saskatchewan and Manitoba.
Taking less than a year to develop, the research team indicates that the PEDV vaccine has successfully protected 100 percent of the piglets in its testing.
In order to have the vaccine available for commercial use in North America, the University of Saskatchewan has partnered with Huvepharma Inc., an animal health firm, headquartered in St. Louis, MO.
Although first discovered in Europe and raging its way through Asian piglet populations, PEDV first made its appearance in the U.S. in 2013 before arriving in Canada the next year.
Since 2013, it is estimated that more than eight million pigs were killed by the virus.
Image purchased via www.fotolia.com.